Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
Cutaneous metastases (CMs) account for 2% of all skin malignancies, and nearly 70% of CMs in women originate from breast cancer (BC). CMs are usually associated with poor prognosis, are difficult to treat, and can pose diagnostic problems, such as in histopathological diagnosis when occurring long a...
Guardado en:
Autores principales: | Silvia González-Martínez, David Pizarro, Belén Pérez-Mies, Tamara Caniego-Casas, Giuseppe Curigliano, Javier Cortés, José Palacios |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/633030240f00426e8b275e87abb0fd03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel hydrazide compound exerts anti-metastatic effect against breast cancer
por: Dehghani,Soudeh, et al.
Publicado: (2019) -
Metástasis cutáneas de cáncer de mama: revisión de la literatura
por: Hasbún Acuña,Paula, et al.
Publicado: (2017) -
BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
por: Lara,Karlena, et al.
Publicado: (2012) -
Assessment of changes in the brca2 and p53 genes in breast invasive ductal carcinoma in northeast Brazil
por: Ramalho,Eduardo AVF, et al.
Publicado: (2014) -
NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Lu Peng, et al.
Publicado: (2021)